Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1982 Aug;46(2):260–265. doi: 10.1038/bjc.1982.191

Influence of inhibitors of serotonin uptake on intestinal epithelium and colorectal carcinomas.

P J Tutton, D H Barkla
PMCID: PMC2011088  PMID: 6983886

Abstract

Previous studies have shown that in certain tissues, including colonic carcinomas, cell proliferation may be promoted by serotonin, and indirect evidence suggests that the effects of this amine on colonic tumours involves a cellular-uptake mechanism. In the present study, two specific inhibitors of serotonin uptake, Citalopram and Fluoxetine, are examined for their effects on cell proliferation and tumour growth. Each of the agents was found to suppress cell division in dimethylhydrazine-induced colonic tumours in rats, and to retard the growth of 2 out of 3 lines of human colonic tumours propagated as xenografts in immune-deprived mice.

Full text

PDF
260

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barkla D. H., Tutton P. J. Influence of histamine and serotonin antagonists on the growth of xenografted human colorectal tumors. J Natl Cancer Inst. 1981 Dec;67(6):1207–1211. [PubMed] [Google Scholar]
  2. Christensen A. V., Fjalland B., Pedersen V., Danneskiold-Samsoe P., Svendsen O. Pharmacology of a new phthalane (Lu 10-171), with specific 5-HT uptake inhibiting properties. Eur J Pharmacol. 1977 Jan 21;41(2):153–162. doi: 10.1016/0014-2999(77)90204-7. [DOI] [PubMed] [Google Scholar]
  3. Fuller R. W., Wong D. T. Inhibition of serotonin reuptake. Fed Proc. 1977 Jul;36(8):2154–2158. [PubMed] [Google Scholar]
  4. Gershon M. D., Jonakait G. M. Uptake and release of 5-hydroxytryptamine by enteric 5-hydroxytryptaminergic neurones: effects of fluoxetine (Lilly 110140) and chlorimipramine. Br J Pharmacol. 1979 May;66(1):7–9. doi: 10.1111/j.1476-5381.1979.tb16089.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hyttel J. Effect of a selective 5-HT uptake inhibitor--Lu 10-171--on rat brain 5-HT turnover. Acta Pharmacol Toxicol (Copenh) 1977 Mar;40(3):439–446. [PubMed] [Google Scholar]
  6. Masala A., Delitala G., Devilla L., Alagna S., Rovasio P. P. Enhancement of insulin-induced prolactin secretion by fluoxetine in man. J Clin Endocrinol Metab. 1979 Sep;49(3):350–352. doi: 10.1210/jcem-49-3-350. [DOI] [PubMed] [Google Scholar]
  7. Meltzer H. Y., Young M., Metz J., Fang V. S., Schyve P. M., Arora R. C. Extrapyramidal side effects and increased serum prolactin following fluoxetine, a new antidepressant. J Neural Transm. 1979;45(2):165–175. doi: 10.1007/BF01250091. [DOI] [PubMed] [Google Scholar]
  8. Neff N. H., Yang H. Y. Another look at the monoamine oxidases and the monoamine oxidase inhibitor drugs. Life Sci. 1974 Jun 1;14(11):2061–2074. doi: 10.1016/0024-3205(74)90089-7. [DOI] [PubMed] [Google Scholar]
  9. Steel G. G., Courtenay V. D., Rostom A. Y. Improved immune-suppression techniques for the exongrafting of human tumours. Br J Cancer. 1978 Feb;37(2):224–230. doi: 10.1038/bjc.1978.30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Tutton P. J., Barkla D. H. Evaluation of the cytotoxicity of dihydroxytryptamines and 5-hydroxytryptamine antagonists as cytotoxic agents in dimethylhydrazine-induced adenocarcinomata. Cancer Chemother Pharmacol. 1978;1(4):209–213. doi: 10.1007/BF00257151. [DOI] [PubMed] [Google Scholar]
  11. Tutton P. J., Barkla D. H. The influence of serotonin on the mitotic rate in the colonic crypt epithelium and in colonic adenocarcinoma in rats. Clin Exp Pharmacol Physiol. 1978 Jan-Feb;5(1):91–94. doi: 10.1111/j.1440-1681.1978.tb00657.x. [DOI] [PubMed] [Google Scholar]
  12. Tutton P. J., Steel G. G. Influence of biogenic amines on the growth of xenografted human colorectal carcinomas. Br J Cancer. 1979 Nov;40(5):743–749. doi: 10.1038/bjc.1979.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Wong D. T., Horng J. S., Bymaster F. P., Hauser K. L., Molloy B. B. A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. Life Sci. 1974 Aug 1;15(3):471–479. doi: 10.1016/0024-3205(74)90345-2. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES